Savant Capital LLC Sells 2,510 Shares of HCA Healthcare, Inc. $HCA

Posted by George Bondi on Jun 3rd, 2026

Savant Capital LLC lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 55.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,038 shares of the company’s stock after selling 2,510 shares during the period. Savant Capital LLC’s holdings in HCA Healthcare were worth $951,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in the company. Moors & Cabot Inc. increased its stake in shares of HCA Healthcare by 2.5% during the fourth quarter. Moors & Cabot Inc. now owns 931 shares of the company’s stock worth $435,000 after purchasing an additional 23 shares during the period. Intech Investment Management LLC increased its stake in HCA Healthcare by 10.0% during the 4th quarter. Intech Investment Management LLC now owns 55,273 shares of the company’s stock worth $25,805,000 after acquiring an additional 5,019 shares during the period. Baker Avenue Asset Management LP increased its stake in HCA Healthcare by 2.1% during the 4th quarter. Baker Avenue Asset Management LP now owns 12,426 shares of the company’s stock worth $5,801,000 after acquiring an additional 253 shares during the period. Huntington National Bank increased its stake in HCA Healthcare by 6.1% during the 4th quarter. Huntington National Bank now owns 5,127 shares of the company’s stock worth $2,394,000 after acquiring an additional 293 shares during the period. Finally, Geode Capital Management LLC increased its stake in HCA Healthcare by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after acquiring an additional 13,565 shares during the period. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on HCA. Jefferies Financial Group restated a “buy” rating and set a $525.00 price objective on shares of HCA Healthcare in a research note on Friday, April 24th. Wells Fargo & Company reduced their target price on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a report on Monday, April 27th. Weiss Ratings downgraded HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, May 18th. Leerink Partners reduced their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Finally, Oppenheimer reduced their target price on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $515.77.

View Our Latest Stock Analysis on HCA

HCA Healthcare Stock Down 1.1%

NYSE HCA opened at $366.77 on Wednesday. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52. The company has a market cap of $81.36 billion, a price-to-earnings ratio of 12.61, a price-to-earnings-growth ratio of 1.18 and a beta of 1.12. The business’s fifty day moving average is $449.37 and its 200 day moving average is $480.24.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same period last year, the business earned $6.45 EPS. The company’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.9%. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.